The Ozempic lawsuit refers to thousands of personal injury lawsuits filed against Novo Nordisk, the manufacturer of Ozempic (semaglutide), by patients who allege the drug caused severe gastrointestinal injuries, including gastroparesis (stomach paralysis), and vision loss (NAION), without adequate warning
Weeks 1-4: 0.25 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 5-8: 0.5 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 9-12: 1.0 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 13-16: 1.7 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Week 17 and beyond: 2.4 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Some providers modify this schedule based on individual tolerance
The risk is relevant enough that the Food and Drug Administration has long required GLP-1 drugs to carry warnings advising people with a higher risk, such as those with a family history of certain cancers, to avoid using them
- Manage Stress: Stress can make digestive symptoms worse, so finding ways to relax, like yoga or meditation, can be really helpful
